On the Future of Species: Authoring Life By Means of Artificial Biological Intelligence
The convergence of AI and synthetic biology is bringing us to the threshold of making biology programmable, writing entirely new forms of life from scratch. AI-driven genome writing, the ability to design and synthesize entire genomes de novo, promises to transform medicine, accelerate drug discovery, and unlock entirely new categories of biological engineering.
Join us for an evening with the author, Adrian Woolfson, followed by a moderated discussion with Sukrit Silas.
Speakers
Adrian Woolfson (Author) — Co-founder and CEO of Genyro Inc. and author of On the Future of Species (MIT Press). Previously Global Clinical Lead for Immuno-Oncology/Hematology at Pfizer and EVP of R&D at Sangamo Therapeutics, where he led the first study to edit the genome of a living person. Opinions contributor to the Wall Street Journal. Woolfson studied medicine at Balliol College Oxford and trained at the MRC Laboratory of Molecular Biology Cambridge, where he did his PhD with Nobel Prize winner César Milstein. He was the Charles and Katherine Darwin Research Fellow at Darwin College Cambridge.
Sukrit Silas (Moderator) — UCSF Assistant Professor in the Department of Microbiology and Immunology, Assistant Investigator at the Gladstone Institutes, and co-founder of BillionToOne. Gates Cambridge Scholarship.
Schedule
5:30 pm: Doors open & networking
6:15 pm: Author presentation
6:45 pm: Moderated discussion
7:15 pm: Audience Q&A
7:30 pm: Networking & close
Books can be purchased online at Penguin Random House. Light refreshments will be served.
Hosted by the University of Cambridge Alumni Association, Northern California